Company news
Currenc Group Inc. news in 2022
Currenc Group Inc.'s news releases, calls and decks from 2022, newest first.
CURE Pharmaceutical Letter to Shareholders
December 14, 2022
CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins
November 21, 2022
Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference
November 9, 2022
Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV
October 23, 2022
Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins
September 1, 2022
CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman
August 15, 2022
CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call
August 8, 2022
CURE Pharmaceutical Announces the Appointment of New Board Member
August 1, 2022
CURE Pharmaceutical Announces Teleconference With Investors
July 31, 2022
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
July 27, 2022
CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell...
May 11, 2022
Sera Labs Inc. Products Now Available at Walmart, Bed Bath & Beyond, CVS and Target.com
April 13, 2022
CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico
March 2, 2022